Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators

Journal of Toxicological Sciences

Volumn 31, Issue 5, 2006, Pages 471-490

  Tamura, Kotaro ^a   Ono, Atsushi ^a   Miyagishima, Toshikazu ^a   Nagao, Taku ^b   Urushidani, Tetsuro ^a,c  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Hepatotoxicity; Peroxisome proliferator; Toxicogenomics

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; ACETYLSALICYLIC ACID; ALLOPURINOL; ALLYL ALCOHOL; BENZBROMARONE; CARBAMAZEPINE; CARBON TETRACHLORIDE; CHLORPROMAZINE; CLOFIBRATE; COUMARIN; CYCLOPHOSPHAMIDE; DIAZEPAM; DICLOFENAC; ETHIONINE; GEMFIBROZIL; HEXACHLOROBENZENE; INDOMETACIN; ISONIAZID; METHAPYRILENE; METHOTREXATE; NITROFURANTOIN; OMEPRAZOLE; PARACETAMOL; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENOBARBITAL; PHENYLBUTAZONE; PIRINIXIC ACID; UNINDEXED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE REGULATION; CARBOHYDRATE METABOLISM; CELL ADHESION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CLUSTER ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION PROFILING; GENOMICS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIVER CELL; LIVER TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TOXICOLOGY; TRANSCRIPTION INITIATION; XENOBIOTIC METABOLISM;

EID: 33846012209     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.31.471     Document Type: Article

References (23)

1. Barrero, M.J., Camarero, N., Marrero, P.F. and Haro, D. (2003): Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element. Biochem. J., 369, 721-729.
2. Bichet, N., Cahard, D., Fabre, G., Remandet, B., Gouy, D. and Cano, J.P. (1990): Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture. Toxicol. Appl. Pharmacol., 106, 509-517.
3. Boitier, E., Gautier, J.C. and Roberts, R. (2003): Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: Relevance for human health and disease. Comp. Hepatol., 2, 3.
4. Brandt, J.M., Djouadi, F. and Kelly, D.P. (1998): Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J. Biol. Chem., 273, 23786-23792.
5. Castelein, H., Gulick, T., Declercq, P.E., Mannaerts, G.P., Moore, D.D. and Baes, M.I. (1994): The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem., 269, 26754-26758.
6. Corton, J.C., Fan, L.Q., Brown, S., Anderson, S.P., Bocos, C., Cattley, R.C., Mode, A. and Gustafsson, J.A. (1998): Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol. Pharmacol., 54, 463-473.
7. Decker, K. (1990): Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem., 192, 245-261.
8. Gervois, P., Vu-Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J.C., Kooistra, T. and Staels, B. (2001): Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J. Biol. Chem., 276, 33471-33477.
9. Horie, S. and Suga, T. (1985): Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid. Biochem. Pharmacol., 34, 1357-1362.
10. Kockx, M., Gervois, P.P., Poulain, P., Derudas, B., Peters, J.M., Gonzalez, F.J., Princen, H.M., Kooistra, T. and Staels, B. (1999): Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha. Blood, 93, 2991-2998.
11. Kramer, J.A., Blomme, E.A., Bunch, R.T., Davila, J.C., Jackson, C.J., Jones, P.F., Kolaja, K.L. and Curtiss, S.W. (2003): Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Toxicol. Pathol., 31, 417-431.
12. Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M. and Kliewer, S.A. (1997): Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem., 272, 3406-3410.
13. McGowan, S.E., Jackson, S.K., Doro, M.M. and Olson, P.J. (1997): Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. Am. J. Physiol., 273, L1249-L1257.
14. Michalik, L., Desvergne, B. and Wahli, W. (2004): Peroxisome- proliferator-activated receptors and cancers: Complex stories. Nat. Rev. Cancer, 4, 61-70.
15. Ogata, T., Miyauchi, T., Sakai, S., Irukayama-Tomobe, Y., Goto, K. and Yamaguchi, I. (2002): Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin. Sci. (Lond), 103, (Suppl 48), 284S-288S.
16. Ogata, T., Miyauchi, T., Irukayama-Tomobe, Y., Takanashi, M., Goto, K. and Yamaguchi, I. (2004): The Peroxisome Proliferator-activated Receptor alpha Activator Fenofibrate Inhibits Endothelin-1-induced Cardiac Fibroblast Proliferation. J. Cardiovasc. Pharmacol., 44, (Suppl 1), S279-S282.
17. Parzefall, W., Berger, W., Kainzbauer, E., Teufelhofer, O., Schulte-Hermann, R. and Thurman, R.G. (2001): Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis, 22, 519-523.
18. Rolfe, M., James, N.H. and Roberts, R.A. (1997): Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis, 18, 2277-2280.
19. Rose, M.L., Germolec, D.R., Schoonhoven, R. and Thurman, R.G. (1997): Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis, 18, 1453-1456.
20. Tanaka, Y., Nouchi ,T. , Yamane, M., Irie, T., Miyakawa, H., Sato, C. and Marumo, F. (1991): Phenotypic modulation in lipocytes in experimental liver fibrosis. J. Pathol., 164, 273-278.
21. Tang, C., Cho, H.P., Nakamura, M.T. and Clarke, S.D. (2003): Regulation of human delta-6 desaturase gene transcription: Identification of a functional direct repeat-1 element. J. Lipid Res., 44, 686-695.
22. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992): The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
23. Urushidani, T. and Nagao, T. (2005): Toxicogenomics: The Japanese initiative. In Handbook of Toxicogenomics - Strategies and Applications (Borlak, J., ed.), pp. 623-631. Wiley - VCH.